5-Year Results from a Prospective Phase II Trial of Ten Fractions Hypofractionated Radiotherapy in Locally Advanced Breast Cancer

被引：0
|
作者：
Pinnaro, P. [1 ]
Takanen, S. [1 ]
Marucci, L. [1 ]
Giannarelli, D. [2 ]
Vici, P. [1 ]
Da Silva, A. Borges [1 ]
Sanguineti, G. [1 ]
机构：
[1] IIRCCS Regina Elena Natl Canc Inst, Rome, Italy
[2] Fdn Policlin Univ Gemelli IRCCS, Rome, Italy
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1110
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [1] Hypofractionated adjuvant radiotherapy and concomitant trastuzumab for breast cancer: 5-year results
    Pasetti, M.
    Fodor, A.
    Sini, C.
    Zerbetto, F.
    Mangili, P.
    Signorotto, P.
    Dell'Oca, I.
    Gumina, C.
    Azizi, M.
    Deli, A. M.
    Passoni, P.
    Slim, N.
    Deantoni, C. L.
    Chiorda, B. Noris
    Foti, S.
    Chiara, A.
    Rossi, G.
    Fiorino, C.
    Bolognesi, A.
    Di Muzio, N. G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S630 - S630
  • [2] Hypofractionated radiotherapy in locally advanced breast cancer
    Carvalho, A. C.
    Fernandes, P.
    Casalta-Lopes, J.
    Cleto, A.
    Borrego, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S568 - S569
  • [3] GEMOX plus hypofractionated radiotherapy for unresectable locally advanced pancreatic cancer: Results from a phase II study
    Passardi, A.
    Scarpi, E.
    Neri, E.
    Parisi, E.
    Ghigi, G.
    Ercolani, G.
    Gardini, A.
    La Barba, G.
    Pagan, F.
    Gardini, A. Casadei
    Frassineti, L. G.
    Ferroni, F.
    Valgiusti, M.
    Darwish, S. A. M. Z. M.
    Romeo, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 249 - 249
  • [4] hypofractionated adjuvant radiotherapy in locally advanced breast cancer
    Aly, A.
    Lasheen, S.
    Attia, H.
    Khalaf, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S919 - S920
  • [5] Efficacy of Hypofractionated Palliative Radiotherapy in Locally Advanced Breast Cancer
    Dulley, L. F.
    Li, S.
    Ah-See, M. W.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S35 - S36
  • [6] 5-year results of HDR brachytherapy, plus radiotherapy and ADT for intermediate prostate cancer: a phase II trial
    Jolicoeur, M.
    Tetreault-Laflamme, A.
    Nguyen-Huynh, T. V.
    Benoit, N.
    Guay, J. P.
    Fortin, B.
    Vincent, F.
    Lambert, C.
    Saad, F.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S562 - S563
  • [7] Hypofractionated radiotherapy with 5-fluorouracil radiosensitization for locally ''far advanced'' breast cancer
    Kosma, L
    Koukourakis, M
    Skarlatos, J
    Zambatis, C
    Ardavanis, A
    Beroukas, K
    Yannakakis, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (06): : 562 - 566
  • [8] Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial
    Reboucas, Lievin Matos
    Campos, Conceicao Souza
    D'Amico, Giovanna Melicio
    Lustosa, Alysson Bastos
    Fregnani, Jose Humberto
    BREAST JOURNAL, 2019, 25 (05): : 953 - 957
  • [9] Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: Results of a phase II trial
    Tubiana-Hulin, Michele
    Becette, Veronique
    Bieche, Ivan
    Mauriac, Louis
    Romieu, Gilles
    Bibeau, Frederic
    MacGrogan, Gaetan
    Bourgeois, Hugues
    Chollet, Philippe
    Defrance, Remy
    Spyratos, Frederique
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2689 - 2696
  • [10] Preoperative hypofractionated radiotherapy (RT) in patients with locally advanced myxoid liposarcomas: Interim analysis of prospective phase II clinical trial
    Paterczyk, H. M. Kosela
    Spalek, M.
    Wagrodzki, M.
    Borkowska, A.
    Szumera-Cieckiewicz, A.
    Cieszanowski, A.
    Morysinski, T.
    Palucki, J.
    Rutkowski, P. L.
    ANNALS OF ONCOLOGY, 2018, 29
12345